Compare Hexindo Adiperkasa Tbk. (HEXA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hexindo Adiperkasa Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Hexindo Adiperkasa Tbk. trades at Rp4,420 (market cap 3.66T, 165.4K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Hexindo Adiperkasa Tbk. is far larger — about 21.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Hexindo Adiperkasa Tbk. is more actively traded (165.4K versus 71K). Which is the better fit depends on your goals.
| HEXA | OBAT | |
|---|---|---|
Market Cap | 3.66T | 167.37B |
Volume | 165.4K | 71K |
Lot | 1.65K | 710 |
Turnover | 732.19M | 17.51M |
Average Price | 4,426.75 | 246.63 |
Value | 732.19M | 17.51M |
Indicative Equilibrium Price | 4,420 | 246 |
Indicative Equilibrium Volume | 56 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hexindo Adiperkasa Tbk.
PT Hexindo Adiperkasa Tbk (the Company) was established on November 28, 1988 based on notarial deed No.37 of Mohamad Ali. The deed of establishment was approved by the Ministry of Justice in its decision letter No. C2-4389.HT.01.01.TH.89 dated May 12, 1989 and was published in Supplement No. 1251 of the State Gazette No.54 dated July7, 1989. Presently, the Company acts as a distributor of certain heavy equipment and related spare parts with the trademark of Hitachi, John Deere and Ammann. The Company’s registration statement for the public offering of its 10 million shares of stocks (with Rp 1000 per value per share) at on offer price of Rp 2,800 per share become affective in accordance with the letter No.S-1958/PM/1994 dated December 5, 1994 issued by the Chairman of the Capital Market Supervisory Agency (BAPEPEAM). The excess of the proceeds over the par value of the shares of stock was recorded as “Capital paid in excess of par value”. The Company’s registration statement for the first limited public offering of 42 million shares to stockholders with pre-emptive rights (with Rp 1,000 per value per share) at an offer price of Rp 1,000 per share became effective in accordance with the letter No.S-1264/PM/1998 dated June 19, 1998 issued by the Chairman of BAPEPAM.
Read more on HEXA →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
